A
A4Cell
A4Cell (legally Arrays for Cell Nanodevices, S.L.) is a Madrid-based biotech spin-off from the Institute of Microelectronics of Barcelona (IMB-CNM, CSIC), founded in 2018. It develops SPAchip technology - silicon microparticles that can be internalized into living cells to enable real-time, long-term monitoring of intracellular parameters for drug discovery, aiming to reduce reliance on animal models. The company has raised roughly €5-6M across several rounds (including a €3M round in November 2023) from investors such as BeAble Capital, Dreavent Capital and CDTI Innvierte.
SectorsBiotechnology, Life science instrumentation, Single-cell analysis, Drug discovery tools, Deep tech / microelectronics
Start-up MapHealthtech & Bio › R&D tools & software for life sciences
Founders
A
Alberto Hernández Pinto
Co-Founder & Chief Scientific Officer
J
Jaume Esteve
Co-Founder (Researcher, Micro and Nanotools Group, IMB-CNM-CSIC)
J
José Antonio Plaza
Co-Founder (Research Professor / Group Leader, Micro and Nanotools Group, IMB-CNM-CSIC)
J
Juan Pablo Agusil
Co-Founder (Postdoctoral Researcher, IMB-CNM-CSIC)
M
Marta Duch
Co-Founder (Head of Microsystems Area, IMB-CNM-CSIC)
Global models 5
110x Genomics
United States · www.10xgenomics.com ↗
Leading single-cell analysis platform company; closest large-scale comparable in the single-cell/intracellular monitoring instrumentation space, though 10x is now public.
$300M+Comparable
MMission Bio
United States · missionbio.com ↗
Develops single-cell multi-omics platforms for research and clinical use, directly comparable to A4Cell's single-cell analysis focus.
$190MComparable
SScipher Medicine
United States · sciphermedicine.com ↗
Uses molecular/cellular profiling tools to guide precision medicine, similar life-science tooling model to A4Cell.
$150M+Comparable
BBerkeley Lights (Phenomex/Bruker Cellular Analysis)
United States · www.brukercellularanalysis.com ↗
Developed microfluidic/optofluidic chip-based platforms for single live-cell analysis, a close technological analogue to A4Cell's chip-based single-cell monitoring.
$300M+ (pre-IPO/acquisition)Comparable
DDeep Bio / Deepcell
United States · deepcell.com ↗
AI- and microfluidics-driven single-cell morphology and analysis platform for drug discovery, similar target market and value proposition to A4Cell.
$60M+Comparable
In the same niche 26 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 4
Open as list →
BBeAble Capital
beablecapital.com
CCentro para el Desarrollo Tecnológico y la Innovación
www.cdti.es
DDreavent Capital
I
Ideas de Bomberos
Funding rounds 5
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-10-19 | Seed (estimated) | €3M |
Dreavent
+2 more
|
| 2021-12-21 | Seed | €1.25M |
Lead not disclosed
+3 more
|
| 2021-01-14 | Seed (estimated) | €1.2M | CDTI, BeAble Capital |
| 2019-07-04 | Seed (estimated) | €650K | BeAble Capital (estimated lead) |
| 2018-01 | Pre-seed (estimated) | €158K | BeAble Capital (estimated lead) |
News 3
Open as list →| Published | Article |
|---|---|
| 2024-10-18 |
Biotech Start-Ups Share How They Are Addressing Key Limitations in Disease Models ↗
Technology Networks
2024-10-18 |
| 2024-05-07 |
Monitor What's Happening Inside Your Cells in Real Time ↗
Technology Networks
2024-05-07 |
| 2023-10-19 |
A4CELL Celebrates a Remarkable Year with €3 Million Investment to Transform Living Single Cell Analysis ↗
AseBio
2023-10-19 |